Ultima Genomics Selected for Landmark Large-Scale Immune Profiling Study with IMU Biosciences, UK Biobank and Waters Corporation
IMU Biosciences and UK Biobank will generate a single-cell immune profiling AI foundational dataset from 80,000 blood samples collected from UK Biobank participants using Ultima Genomics' UG200™ Sequencing Platform and the BD Rhapsody™ Single-Cell Platform from Waters Corporation Ultima's...
Covered in this story
What has happened since
- Waters Corporation is up 2.0% since this was published, 2 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Waters Corporation
- TD Cowen: $400 → $475 by Aug 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $WAT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Waters Corporation →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.